全球個人化基因組學市場按測試類型、技術、應用、最終用戶和地區分類

Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球個人化基因組學市場規模估計為 125.5 億美元，預計到 2032 年將達到 381.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 17.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	125.5億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	17.20%	2032年價值預測	381.2億美元

個人化基因組學是一個快速發展的領域，它結合了遺傳學、基因組學和個人化醫療，為了解個人基因組成提供有價值的見解。

市場動態：

全球個人化基因組學市場受多種因素驅動。首先，慢性病發病率的上升和個人化治療的需求推動了對基因檢測服務的需求。個人化基因組學有助於識別患有某些疾病的高風險個體，從而實現早期療育和針對性治療。例如，根據2020年9月發表在《預防慢性病》雜誌上的一篇論文，2018年，51.8%的一般民眾非住院成年人被診斷出患有至少一種特定慢性病。更具體地說，24.6%的成年人患有一種慢性病，27.2%的成年人患有兩種或兩種以上的慢性病。

此外，次世代定序和生物資訊學等技術進步使得基因檢測變得更加容易和便宜，從而擴大了提供個人化基因組服務的公司消費群。

然而，市場中也存在一些限制因素。由於基因資訊高度敏感，如果保護不當，可能會被濫用，因此人們對隱私和資料安全提出了擔憂。監管挑戰以及對基因數據使用和解讀的明確指導方針的需求，也對市場成長構成了挑戰。

儘管面臨諸多挑戰，個人化基因體學市場仍蘊藏著巨大的機會。人工智慧和機器學習演算法與基因分析的整合，可以提高個人化基因組學服務的準確性和效率。此外，直接面對消費者的基因檢測的擴展以及醫療環境中基因檢測的日益普及，為該市場的公司帶來了光明的成長前景。

本研究的主要特點

本報告對全球個人化基因組學市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025 年至 2032 年的市場規模和復合年成長率。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數，介紹了全球個人化基因組學市場的主要企業概況。
本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
可以透過用於分析全球個人化基因組學市場的各種策略矩陣來促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 12.55 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	17.20%	2032 Value Projection:	USD 38.12 Bn

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

This report provides in-depth analysis of the global personalized genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

By Test Type
- Oncology Testing
- Infectious Disease Testing
- Neurological Testing
- Cardiovascular Testing
- Others
By Technology
- PCR-based Tests
- Microarray-based Tests
- Sequencing-based Tests
- Others
By Application
- Diagnostics
- Precision Medicine
- Wellness
- Reproductive Health
- Sports Nutrition & Health
- Lifestyle
- Others
By End User
- Hospitals & Clinics
- Research Centers
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- 23andMe
- Mapmygenome
- Invitea
- Genetic Technology Limited
- Lonza
- Interleukin Genetics, Inc
- GNA Genotek
- Helix
- MyHeritage
- Pathway Genomics
- Veritas Genetics
- Xcode
- Color Genomics
- Myriad Genetics
- Quest Diagnostics
- Bio-Rad Laboratories, Inc.
- Illumina
- Thermo Fisher Scientific
- Qiagen
- Genomic Health
- Nebula Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Genomics, By Test Type
- Market Personalized Genomics, By Technology
- Market Personalized Genomics, By Application
- Market Personalized Genomics, By End User
- Market Personalized Genomics, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing demand for personalized medicine and increase in R&D investments
- High costs and complex data interpretation
- Leveraging Big Data and Artificial Intelligence
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Personalized Genomics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Personalized Genomics Market, By Test Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Neurological Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cardiovascular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Personalized Genomics Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
PCR-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Microarray-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Sequencing-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

7. Global Personalized Genomics Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Wellness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Sports Nutrition & Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Lifestyle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Global Personalized Genomics Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

9. Global Personalized Genomics Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

10. Competitive Landscape

23andMe
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mapmygenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitea
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genetic Technology Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Interleukin Genetics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GNA Genotek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Helix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MyHeritage
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pathway Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Veritas Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Xcode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Color Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Qiagen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genomic Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nebula Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views